Follicular Lymphoma

Common Name(s)

Follicular Lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Follicular Lymphoma" returned 791 free, full-text research articles on human participants. First 3 results:

The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma.
 

Author(s): Chava Perry, Hedva Lerman, Erel Joffe, Nadav Sarid, Odelia Amit, Irit Avivi, Mikhail Kesler, Jonathan Ben-Ezra, Einat Even-Sapir, Yair Herishanu

Journal: Medicine (Baltimore). 2016 Mar;95(9):e2910.

 

Follicular lymphoma (FL) is the 2nd most common type of lymphoma diagnosed in the Western World. Bone marrow (BM) involvement is an adverse prognostic factor in FL, routinely assessed by an arbitrary biopsy of the iliac crest. This study was aimed to investigate the role of positron ...

Last Updated: 6 Mar 2016

Go To URL
5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report.
 

Author(s): Yutaka Tsutsumi, Hiroyuki Ohigashi, Shinichi Ito, Souichi Shiratori, Takanori Teshima

Journal:

 

The loss of CD20 protein expression after a rituximab-containing regimen is one of the resistance mechanisms in non-Hodgkin's lymphoma. Recently, it was reported that 5-azacitidine administration upregulates the expression of CD20 in CD20-negative B-cell acute lymphoblastic leukemia. ...

Last Updated: 3 Feb 2016

Go To URL
Follicular lymphoma: 2015 update on diagnosis and management.
 

Author(s): Arnold Freedman

Journal: Am. J. Hematol.. 2015 Dec;90(12):1171-8.

 

Follicular lymphoma is generally an indolent B cell lymphoproliferative disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by diffuse lymphoadenopathy, bone marrow involvement, splenomegaly, and less commonly other extranodal sites of involvement. ...

Last Updated: 15 Jan 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Follicular Lymphoma" returned 81 free, full-text review articles on human participants. First 3 results:

Colorectal Manifestation of Follicular Lymphoma.
 

Author(s): Masaya Iwamuro, Hiroyuki Okada, Katsuyoshi Takata, Ryuta Takenaka, Tomoki Inaba, Motowo Mizuno, Haruhiko Kobashi, Shouichi Tanaka, Masao Yoshioka, Eisei Kondo, Tadashi Yoshino, Kazuhide Yamamoto

Journal: Intern. Med.. 2016 ;55(1):1-8.

 

Due to their rarity, the endoscopic features and clinical backgrounds of colorectal follicular lymphoma lesions have not yet been fully investigated. The aim of this study was to reveal the characteristics of this disease entity.

Last Updated: 4 Jan 2016

Go To URL
Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review.
 

Author(s): Hugo J A Adams, Rutger A J Nievelstein, Thomas C Kwee

Journal: Ann. Hematol.. 2016 Jan;95(1):11-8.

 

This study aimed to systematically review the prognostic value of interim and end-of-treatment (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in follicular lymphoma during and after first-line therapy. The PubMed/MEDLINE database was searched for relevant original ...

Last Updated: 5 Jan 2016

Go To URL
Targeted Approaches to the Management of Follicular Lymphoma.
 

Author(s): Chaitra Ujjani

Journal: Oncology (Williston Park, N.Y.). 2015 Oct;29(10):760-8.

 

Despite high rates of response to initial chemoimmunotherapy, patients with follicular lymphoma experience frequent relapses, and better treatment options are needed. Several novel biologic agents have been developed based on a greater understanding of the intrinsic factors driving ...

Last Updated: 16 Oct 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma
 

Status: Recruiting

Condition Summary: Follicular Lymphoma

 

Last Updated: 22 Jun 2016

Go to URL